+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Metabolomics Market - Global Forecast 2026-2032- Product Image
Metabolomics Market - Global Forecast 2026-2032- Product Image
New

Metabolomics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674898
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The metabolomics market is undergoing structural transformation, driven by integrated analytical, computational, and translational advances that are reshaping research and clinical pipelines. Senior leaders face a fast-evolving landscape in which technology investment, supply-chain management, and workforce strategies directly impact clinical and commercial outcomes.

Market Snapshot

The metabolomics market grew from USD 3.39 billion in 2025 to USD 3.78 billion in 2026, and is projected to reach USD 7.39 billion by 2032, reflecting a CAGR of 11.76%. This surge is propelled by cross-disciplinary adoption in diagnostics, pharmaceutical research, and personalized health, complemented by rising demand for high-throughput platforms and advanced bioinformatics solutions. The sector’s expansion signals greater integration of metabolomic data into strategic decision-making and operational workflows for industry stakeholders.

Scope & Segmentation

  • Components: Bioinformatics tools and services, including platform-oriented software, databases, and service solutions; Instrumentation such as detection and separation tools, with differentiation between mass spectrometry, surface-based mass analysis, nuclear magnetic resonance spectroscopy, capillary electrophoresis, gas chromatography, high-performance and ultra performance liquid chromatography.
  • Indications: Cardiovascular, metabolic, neurological, and oncological disorders, each with unique analytical requirements and varying regulatory complexity.
  • Applications: Biomarker discovery (spanning oncology and neurology), drug discovery with focus on metabolic pathway mapping, environmental science including pesticide residue and water quality, nutrigenomics (e.g., cardiovascular health, obesity), personalized medicine, and toxicology testing.
  • End-Users: Academic research institutions, contract research organizations, pharmaceutical companies, and biotechnology enterprises with distinct operational demands and investment cycles.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, with each region shaped by infrastructure maturity, regulatory standards, and unique adoption drivers.
  • Technologies: High-resolution mass spectrometry, nuclear magnetic resonance, separation chemistries, and advanced computational tools underpinning scalability and multivariate analyses.

Key Takeaways

  • Recent advances have moved metabolomics from niche science to a strategic pillar in systems biology, enabling actionable insights for diagnostics and therapeutic innovation.
  • The combination of high-resolution detection and robust computational pipelines supports predictive analytics critical for patient stratification, therapeutic monitoring, and regulatory submissions.
  • Standardization and reproducible workflows are increasingly essential as organizations transition from technical proof of concept to operational deployment in clinical and commercial environments.
  • Segmentation based on component, indication, application, and end-user is crucial for organizations to align technology investment with maximum clinical or business value.
  • Regional variation demands tailored commercialization, with partnerships and compliance models adjusting to differing regulatory and funding landscapes across global markets.

Tariff Impact

Tariffs introduced in the United States in 2025 have shifted procurement priorities for laboratories and instrument suppliers. Increased import duties on critical analytical equipment and consumables have led organizations to reexamine sourcing, emphasizing inventory localization, longer-term vendor contracts, and resilience-focused supply chain strategies. Vendors adapt through regional distribution, renegotiated terms, and supply chain reconfiguration to maintain business continuity and support end-user requirements.

Methodology & Data Sources

This report utilizes a multi-method research design, integrating primary interviews with laboratory experts and procurement specialists, supplemented by peer-reviewed literature and validated technical reports. Analytical rigor is maintained through thematic analysis and cross-validation of supplier claims with independent benchmarks, while scenario mapping is used to gauge policy and supply chain impacts. Subject-matter expert peer review ensures technical precision and practical relevance.

Why This Report Matters

  • Equips leaders with evidence-based recommendations to optimize technology integration and capitalize on evolving market segments.
  • Enables informed procurement and partnership decisions by clarifying the interplay of market forces, regional dynamics, and technological differentiation.
  • Supports clear prioritization of investments in workforce, supply chain, and commercialization tailored to the complex metabolomics ecosystem.

Conclusion

The metabolomics market is entering a phase of rapid, strategic evolution, where technical maturity and operational alignment are both essential. Organizations that prioritize interoperable workflows, supply-chain resilience, and collaborative partnerships will be best positioned to achieve clinical and commercial impact.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Metabolomics Market, by Component
8.1. Bioinformatics Tools & Services
8.1.1. Bioinformatics Services
8.1.2. Bioinformatics Tools & Databases
8.2. Metabolomic Instruments
8.2.1. Detection Tools
8.2.1.1. Mass Spectrometry
8.2.1.2. Nuclear Magnetic Resonance Spectroscopy
8.2.1.3. Surface-based Mass Analysis
8.2.2. Separation Tools
8.2.2.1. Capillary Electrophoresis
8.2.2.2. Gas Chromatography
8.2.2.3. High-Performance Liquid Chromatography
8.2.2.4. Ultra Performance Liquid Chromatography
9. Metabolomics Market, by Indication
9.1. Cardiovascular Disorders
9.2. Metabolic Disorders
9.3. Neurological Disorders
9.4. Oncological Disorders
10. Metabolomics Market, by Application
10.1. Biomarker Discovery
10.1.1. Cancer Biomarkers
10.1.2. Neurological Biomarkers
10.2. Drug Discovery
10.2.1. Metabolic Pathways
10.2.2. Target Identification
10.3. Environmental Science
10.3.1. Pesticide Residue Analysis
10.3.2. Water Quality Analysis
10.4. Nutrigenomics
10.4.1. Cardiovascular Health
10.4.2. Obesity Research
10.5. Personalized Medicine
10.5.1. Genomic Studies
10.5.2. Therapeutic Monitoring
10.6. Toxicology Testing
11. Metabolomics Market, by End-User
11.1. Academic Research Institutes
11.2. Contract Research Organizations
11.3. Pharmaceutical & Biotechnology Companies
12. Metabolomics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Metabolomics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Metabolomics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Metabolomics Market
16. China Metabolomics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Afekta Technologies Ltd.
17.6. BASF SE
17.7. Bio-Rad Laboratories, Inc.
17.8. Biocrates Life Science AG
17.9. Bruker Corporation
17.10. Clinical Microbiomics A/S
17.11. Danaher Corporation
17.12. DNA Xperts Private Limited
17.13. General Metabolics
17.14. Hitachi High-Tech Corporation
17.15. Human Metabolome Technologies Inc.
17.16. JASCO Corporation
17.17. Kore Technology Limited
17.18. LECO Corporation
17.19. Merck KGaA
17.20. Metabolon, Inc.
17.21. Shimadzu Corporation
17.22. Techcomp Europe Ltd
17.23. Thermo Fisher Scientific Inc.
17.24. Waters Corporation
List of Figures
FIGURE 1. GLOBAL METABOLOMICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL METABOLOMICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL METABOLOMICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES METABOLOMICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA METABOLOMICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL METABOLOMICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL METABOLOMICS MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL METABOLOMICS MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL METABOLOMICS MARKET SIZE, BY ONCOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC PATHWAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC PATHWAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC PATHWAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL METABOLOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL METABOLOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL METABOLOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL METABOLOMICS MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL METABOLOMICS MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL METABOLOMICS MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL METABOLOMICS MARKET SIZE, BY WATER QUALITY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL METABOLOMICS MARKET SIZE, BY WATER QUALITY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL METABOLOMICS MARKET SIZE, BY WATER QUALITY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL METABOLOMICS MARKET SIZE, BY OBESITY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL METABOLOMICS MARKET SIZE, BY OBESITY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL METABOLOMICS MARKET SIZE, BY OBESITY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL METABOLOMICS MARKET SIZE, BY GENOMIC STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL METABOLOMICS MARKET SIZE, BY GENOMIC STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL METABOLOMICS MARKET SIZE, BY GENOMIC STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL METABOLOMICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL METABOLOMICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL METABOLOMICS MARKET SIZE, BY THERAPEUTIC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS METABOLOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 180. EUROPE METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPE METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 182. EUROPE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 183. EUROPE METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 186. EUROPE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 187. EUROPE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPE METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 189. EUROPE METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 191. EUROPE METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 193. EUROPE METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 208. AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. AFRICA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 210. AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 211. AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 212. AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 213. AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 214. AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 215. AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. AFRICA METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 217. AFRICA METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 218. AFRICA METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 219. AFRICA METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 220. AFRICA METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 221. AFRICA METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL METABOLOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. ASEAN METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. ASEAN METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 239. ASEAN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 240. ASEAN METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 241. ASEAN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 242. ASEAN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 243. ASEAN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 244. ASEAN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. ASEAN METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 246. ASEAN METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 247. ASEAN METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 248. ASEAN METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 249. ASEAN METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 250. ASEAN METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 251. GCC METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. GCC METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 253. GCC METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 254. GCC METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 255. GCC METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 256. GCC METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 257. GCC METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 258. GCC METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. GCC METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 260. GCC METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 261. GCC METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 262. GCC METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 263. GCC METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 264. GCC METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 279. BRICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. BRICS METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 281. BRICS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 282. BRICS METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 283. BRICS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 284. BRICS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 285. BRICS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 286. BRICS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. BRICS METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 288. BRICS METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 289. BRICS METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 290. BRICS METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 291. BRICS METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 292. BRICS METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 293. G7 METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. G7 METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 295. G7 METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 296. G7 METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 297. G7 METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 298. G7 METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 299. G7 METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 300. G7 METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 301. G7 METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 302. G7 METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 303. G7 METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 304. G7 METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 305. G7 METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 306. G7 METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 307. NATO METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 308. NATO METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 309. NATO METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 310. NATO METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 311. NATO METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 312. NATO METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 313. NATO METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 314. NATO METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. NATO METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 316. NATO METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 317. NATO METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 318. NATO METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 319. NATO METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 320. NATO METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 321. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 322. UNITED STATES METABOLOMICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 323. UNITED STATES METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 324. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 325. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 326. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 327. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2032 (USD MILLION)
TABLE 328. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 329. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 330. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 331. UNITED STATES METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 332. UNITED STATES METABOLOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, 2018-2032 (USD MILLION)
TABLE 333. UNITED STATES METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, 2018-2032 (USD MILLION)
TABLE 334. UNITED STATES METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, 2018-2032 (USD MILLION)
TABLE 335. UNITED STATES METABOLOMICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 336. CHINA METABOLOMICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 337. CHINA METABOLOMICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 338. CHINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2032 (USD MILLION)
TABLE 339. CHINA METABOLOMICS MARKET SIZE, BY METABOLOMIC INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 340. CHINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2032 (USD MILLION)
TABLE 341. CHINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS,

Companies Mentioned

The key companies profiled in this Metabolomics market report include:
  • Afekta Technologies Ltd.
  • BASF SE
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Science AG
  • Bruker Corporation
  • Clinical Microbiomics A/S
  • Danaher Corporation
  • DNA Xperts Private Limited
  • General Metabolics
  • Hitachi High-Tech Corporation
  • Human Metabolome Technologies Inc.
  • JASCO Corporation
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • Metabolon, Inc.
  • Shimadzu Corporation
  • Techcomp Europe Ltd
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 7.39 Billion
Compound Annual Growth Rate11.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Metabolomics Market Report 2025 - Product Image

Metabolomics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Metabolomics Services Market Report 2025 - Product Image

Metabolomics Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Metabolomics Market Report and Forecast 2025-2034 - Product Image

Metabolomics Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Metabolomics Market Report 2025-2033 - Product Image

Metabolomics Market Report 2025-2033

  • Report
  • 143 Pages
  • Global
From
Untargeted Metabolomics Market - Global Forecast 2025-2030 - Product Image

Untargeted Metabolomics Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.